Effects of vedolizumab on health‐related quality of life in patients with ulcerative colitis: results from the randomised GEMINI 1 trial

por Feagan, B. G., Patel, H., Colombel, J.‐F., Rubin, D. T., James, A., Mody, R., Lasch, K.
Publicado 2016

Uric acid levels are independent of anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn’s disease: A reappraisal of the role of S. cerevisiae in this setting

por Sendid, B., Jawhara, S., Sarter, H., Maboudou, P., Thierny, C., Gower-Rousseau, C., Colombel, J. F., Poulain, D.
Publicado 2018

Adalimumab maintains remission of Crohn's disease after up to 4 years of treatment: data from CHARM and ADHERE

por Panaccione, R, Colombel, J-F, Sandborn, W J, D'Haens, G, Zhou, Q, Pollack, P F, Thakkar, R B, Robinson, A M
Publicado 2013

Structural robustness of the gut mucosal microbiota is associated with Crohn's disease remission after surgery

por Mondot, S, Lepage, P, Seksik, P, Allez, M, Tréton, X, Bouhnik, Y, Colombel, J F, Leclerc, M, Pochart, P, Doré, J, Marteau, P
Publicado 2016

Randomised clinical study: discrepancies between patient‐reported outcomes and endoscopic appearance in moderate to severe ulcerative colitis

por Jharap, B., Sandborn, W. J., Reinisch, W., D'Haens, G., Robinson, A. M., Wang, W., Huang, B., Lazar, A., Thakkar, R. B., Colombel, J.‐F.
Publicado 2015

Effects of concomitant immunomodulators on the pharmacokinetics, efficacy and safety of adalimumab in patients with Crohn's disease or ulcerative colitis who had failed conventiona...

por Colombel, J.‐F., Jharap, B., Sandborn, W. J., Feagan, B., Peyrin‐Biroulet, L., Eichner, S. F., Robinson, A. M., Mostafa, N. M., Zhou, Q., Thakkar, R. B.
Publicado 2016

The schistosome glutathione S-transferase P28GST, a unique helminth protein, prevents intestinal inflammation in experimental colitis through a Th2-type response with mucosal eosin...

por Driss, V, El Nady, M, Delbeke, M, Rousseaux, C, Dubuquoy, C, Sarazin, A, Gatault, S, Dendooven, A, Riveau, G, Colombel, J F, Desreumaux, P, Dubuquoy, L, Capron, M
Publicado 2016

Long‐term efficacy and safety of ustekinumab for Crohn's disease through the second year of therapy

por Sandborn, W. J., Rutgeerts, P., Gasink, C., Jacobstein, D., Zou, B., Johanns, J., Sands, B. E., Hanauer, S. B., Targan, S., Ghosh, S., de Villiers, W. J. S., Colombel, J.‐F., Feagan, B. G.
Publicado 2018

Randomised clinical trial: a placebo‐controlled study of intravenous golimumab induction therapy for ulcerative colitis

por Rutgeerts, P., Feagan, B. G., Marano, C. W., Padgett, L., Strauss, R., Johanns, J., Adedokun, O. J., Guzzo, C., Zhang, H., Colombel, J.‐F., Reinisch, W., Gibson, P. R., Sandborn, W. J.
Publicado 2015

Bacteriome and Mycobiome Interactions Underscore Microbial Dysbiosis in Familial Crohn’s Disease

por Hoarau, G., Mukherjee, P. K., Gower-Rousseau, C., Hager, C., Chandra, J., Retuerto, M. A., Neut, C., Vermeire, S., Clemente, J., Colombel, J. F., Fujioka, H., Poulain, D., Sendid, B., Ghannoum, M. A.
Publicado 2016

Adalimumab for the treatment of fistulas in patients with Crohn’s disease

por Colombel, J-F, Schwartz, D A, Sandborn, W J, Kamm, M A, D’Haens, G, Rutgeerts, P, Enns, R, Panaccione, R, Schreiber, S, Li, J, Kent, J D, Lomax, K G, Pollack, P F
Publicado 2009

An in-depth study of Crohn's disease in two French families()

por Kruiningen, H.J.Van, Colombel, J.F., Cartun, R.W., Whitlock, R.H., Koopmans, M., Kangro, H.O., Hoogkamp-Korstanje, J.A.A., Lecomte-Houcke, M., Devred, M., Paris, J.C., Cortot, A.
Publicado 1993

Aluminum enhances inflammation and decreases mucosal healing in experimental colitis in mice

por Pineton de Chambrun, G, Body-Malapel, M, Frey-Wagner, I, Djouina, M, Deknuydt, F, Atrott, K, Esquerre, N, Altare, F, Neut, C, Arrieta, M C, Kanneganti, T-D, Rogler, G, Colombel, J-F, Cortot, A, Desreumaux, P, Vignal, C
Publicado 2014